Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

Centessa’s OX2R agonist pipeline features a potential best-in-class therapeutic with important promise to meaningfully enhance outcomes throughout a spread of sleep-wake disorders Acquisition expands Lilly’s neuroscience portfolio and capabilities into sleep drugs INDIANAPOLIS and BOSTON and LONDON, March 31, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…

Read More
QNX and NVIDIA Deepen Collaboration to Advance Safety-Critical Edge AI Across Robotics, Medical, and Industrial Systems

QNX and NVIDIA Deepen Collaboration to Advance Safety-Critical Edge AI Across Robotics, Medical, and Industrial Systems

QNX OS for Safety 8.0 and NVIDIA IGX Thor ship a unified platform for actual‑time management, practical security, and AI on the industrial edge HANNOVER, DE / ACCESS Newswire / April 20, 2026 / At Hannover Messe, QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB) in the present day introduced an growth of its collaboration with…

Read More